Publications

5891 Results

Serum adiponectin, c-peptide and leptin and risk of symptomatic beign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial

Authors
JM Shenk;AR Kristal;ML Neuhouser;CM Tangen;E White;DW Lin
Journal / Conference
Prostate 69(12):1303-1311
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial

Authors
Z Gong;AR Kristal;JM Schenk;CM Tangen;P Goodman;IM Thompson
Journal / Conference
Cancer 1154(16):3661-3669
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

The performance of PSA for predicting prostate cancer after a prior negative prostate biopsy

Authors
CM Tangen
Journal / Conference
Prostate Cancer Screening, 2nd edition, D Ankerst, IM Thompson, C Tangen, eds., Human Press, New York, NY, ch 7, pp 71-78
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial (Southwest Oncology Group Study S9217). PMC2877916;PMID:19887582

Authors
E Platz;C Till;P Goodman;H Parnes;WD Figg;D Albanes;ML Neuhouser;AR Kristal;EA Klein;IM Thompson
Journal / Conference
Cancer Epidemiology, Biomarkers and Prevention 18(11):2807-2813
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomized controlled trial [PMID19632716]

Authors
KS Albain;RS Swann;VW Rusch;AT Turrisi;FA Shepherd;C Smith;Y Chen;RB Livingston;RH Feins;DR Gandara;WA Fry;G Darling;DH Johnson;MR Green;RC Miller;J Ley;WT Sause;JC Cox
Journal / Conference
Lancet 374:379-386
Year
2009
Research Committee(s)
Lung
Study Number(s)
SWOG-9336

Follicular lymphomas with and without translocation t(14:18) differ in gene expression profiles and genetic alterations [PMID19471018; PMC2716022]

Authors
E Leich;I Salaverria;S Bea;A Zettl;G Wright;V Moreno;RD Gascoyne;RM Braziel;L Rimsza;DD Weisenburger;J Delabie;ES Jaffe;A Lister;J Fitzgibbon;LM Staudt;EM Hartmann;HK Mueller-Hermelink;E Campo;G Ott;A Rosenwald
Journal / Conference
Blood 114:826-834
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Array-based DNA methylation profiling in follicular lymphoma

Authors
C O'Riain;DM O'Shea;Y Yang;R LeDieu;JF Gribben;K Summers;J Yeboah-Afari;L Bhaw-Rosun;C Fleischmann;CA Mein;T Crook;P Smith;G Kelly;A Rosenwald;G Ott;E Campo;L Rimsza;EB Smeland;WC Chan;N Johnson;RD Gascoyne;S Reimer;R Braziel;WG Wright;LM Staudt;TA Lister;J Fitzgibbon
Journal / Conference
Leukemia 23(10):1858-1866
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1 negative subtype [PMID19880778; PMC2770966]

Authors
A Mozos;C Royo;E Hartmann;D DeJong;C Baro;A Valera;K Fu;DD Weisenburger;J Delabie;SS Chuang;ES Jaffe;S Dave;L Rimsza;R Braziel;RD Gascoyne;F Sole;A Lopez-Guillermo;D Colomer;LM Staudt;A Rosenwald;G Ott;P Jares;E Campo
Journal / Conference
Haematologica 94(11):1555-1562
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial [PMC2836168; PMID19447479]

Authors
M Markman;PY Liu;J Moon;B Monk;L Copeland;S Wilczynski;D Alberts
Journal / Conference
Gynecologic Oncology 114(2):195-198
Year
2009
Research Committee(s)
Gynecologic
Study Number(s)
S9701

Moving to centralized follow-up from a site-based model in a large cancer prevention study

Authors
P Goodman;J Hartline;E Klein
Journal / Conference
Frontiers in Cancer Prevention Research Conference, AACR, poster presentation, abst. #A85, p. 89
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000